OpenAI-backed biotech firm Chai Discovery raises $130M Series B at $1.3B valuation
PositiveArtificial Intelligence
- Chai Discovery, an AI-driven biotech firm backed by OpenAI, has successfully raised $130 million in a Series B funding round, achieving a valuation of $1.3 billion. The company focuses on developing foundation models for drug discovery, particularly in predicting molecular interactions for potential cures.
- This significant funding will enable Chai Discovery to enhance its capabilities in drug design, allowing for the development of a computer-aided design suite that could revolutionize the drug discovery process and accelerate the creation of new therapies.
- The funding landscape for AI-driven startups continues to flourish, as evidenced by other recent successful funding rounds in the sector. This trend highlights the growing investor confidence in AI technologies and their applications across various industries, including healthcare and communication.
— via World Pulse Now AI Editorial System
